ZDHHC3 and neoplasm: Conversely, DHHC3-catalyzed PD-L1 palmitoylation impedes its ubiquitination-mediated degradation, and 2-bromopalmitate can restore anti-tumor immunity by inhibiting DHHC3 (24, 25).